Get started
Work

Real-World Use of Cemiplimab in Advanced/Metastatic Cutaneous Squamous Cell Carcinoma

Year: 2025
Type: article
Study design: Observational Study
Abstract: Background: Despite recent literature on Cemiplimab for advanced/metastatic cutaneous squamous cell carcinoma (cSCC), real-world data on its efficacy and safety remain limited. This study aims to fill this gap by analyzing the clinical outcomes of cemiplimab in a monocentric, real-world setting.
DOI: 10.1016/j.ejcskn.2025.100690
Authors: G. Roccuzzo, E. Bongiovanni, G. Actis Giorgetto, C. Astrua, M. Brizio, G. Cavaliere, P. Fava, S. Ribero, P. Quaglino
Institution: University of Turin
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,340
OpenAlex ID: W4409143673
FWCI:
Cites:
Cited by:
Related to: 10